Ignite Creation Date:
2024-05-06 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05118126
Status:
UNKNOWN
Last Update Posted:
2022-01-12
First Post:
2021-11-01
Brief Title:
Gut Microbiota in ITP
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Study Overview
Official Title:
Diagnostic and Therapeutic Value of Gut Microbiome in Adult Immune Thrombocytopenia
Status:
UNKNOWN
Status Verified Date:
2022-01
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective observational study to explore the significance of gut microbiome in the diagnosis of ITP and to identify the predictive value of baseline gut microbiome for GC resistancerelapse
Detailed Description:
A prospective observational study to 1 collect fecal samples from ITP patients at initial diagnosis baseline and after first-line GC treatment 2 detect the composition of gut microbiome and related metabolites using metagenomic sequencing combined with metabolomics 3 observe the impact of first-line treatment on gut microbiome 4 explore the significance of gut microbiome in the diagnosis of ITP and 5 identify the predictive value of baseline gut microbiome for GC resistancerelapse thus to provide new ideas for clinical diagnosis and treatment of ITP
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None